GE Healthcare Receives FDA Clearance for First X-ray AI to Help Assess Endotracheal Tube Placement

GE Healthcare announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an artificial intelligence (AI) algorithm to help clinicians assess Endotracheal Tube (ETT) placements. The AI solution is one of five included in GE Healthcare’s Critical Care Suite 2.0, an industry-first collection of AI algorithms embedded on a mobile x-ray device for automated measurements, case prioritization and quality control.

Read more here